Investing.com -- Chemed Corporation (NYSE:CHE)公布的第二季度业绩大幅低于分析师预期,导致股价下跌4.9%,这家医疗保健和管道服务提供商同时下调了全年展望。 该公司运营VITAS Healthcare和Roto-Rooter业务,截至2025年6月30日的季度调整后每股收益为4.27美元,远低于分析师预期的5.39美元。收入为6.188亿美元,同比增长...
Source LinkInvesting.com -- Chemed Corporation (NYSE:CHE)公布的第二季度业绩大幅低于分析师预期,导致股价下跌4.9%,这家医疗保健和管道服务提供商同时下调了全年展望。 该公司运营VITAS Healthcare和Roto-Rooter业务,截至2025年6月30日的季度调整后每股收益为4.27美元,远低于分析师预期的5.39美元。收入为6.188亿美元,同比增长...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.